Pembrolizumab
Merck
['mbc', 'impact,(-impacte),(-impacti),(-impactf)', 'bcsm']
happening now: dr reporting on implications of #apobec &amp; other mutational signatures on sensitivity to #et (with/out #cdk 4/6) in hr+ #mbc #bcsm #mskimpact #esmo22 
Medical Oncologist